Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rabitra I 20mg/150mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Astrica Biomedics Pvt Ltd

Salt Composition

Rabeprazole (20mg) + Itopride (150mg)

Overview Rabitra I 20mg/150mg Capsule SR

Gastroesophageal reflux disease (GERD) and peptic ulcers are effectively managed with Rabitra I 20mg/150mg SR capsules, a dual-action formulation. This medication alleviates common acidity symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and treatment duration for Rabitra I 20mg/150mg SR capsules should always follow your physician's instructions, varying depending on individual response and condition severity. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete transparency with your healthcare provider regarding all other medications is crucial due to potential interactions. Common, generally transient side effects include abdominal discomfort, altered bowel habits (diarrhea or constipation), headache, flatulence, fatigue, and hypersalivation. However, any concerning side effects warrant immediate medical attention. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential additive drowsiness. Lifestyle adjustments, including consuming cold milk and avoiding stimulants like coffee, tea, spicy food, and chocolate, can enhance treatment outcomes. Prior to initiating Rabitra I 20mg/150mg SR capsules, inform your doctor of any liver conditions, pregnancy, pregnancy plans, or breastfeeding.

Uses of Rabitra I 20mg/150mg Capsule SR

Heartburn and ulcers stemming from stomach acid

Major Benefits of Rabitra I 20mg/150mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Rabitra I 20mg/150mg SR capsules on an empty stomach.

Common Side effects of Rabitra I 20mg/150mg Capsule SR:

  • Stomach pain
  • Diarrhea
  • Constipation
  • Headache
  • Dizziness
  • Flatulence
  • Weakness
  • Flu-like symptoms
  • Increased saliva production

How to use Rabitra I 20mg/150mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 20mg/150mg Rabitra I SR Capsule whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

How Rabitra I 20mg/150mg Capsule SR works:

Rabitra I 20mg/150mg sustained-release capsules contain rabeprazole and itopride, acting synergistically to alleviate gastrointestinal distress. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from heartburn and acid indigestion. Itopride, a prokinetic agent, targets the brain's vomiting center and enhances upper gastrointestinal motility, facilitating efficient food passage.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when drinking alcohol while taking Rabitra I 20mg/150mg sustained-release capsules. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Rabitra I 20mg/150mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Rabitra I 20mg/150mg sustained-release capsules and breastfeeding are currently unavailable. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving may be impaired by Rabitra I 20mg/150mg SR Capsules, which can cause drowsiness, dizziness, and visual disturbances. Avoid operating a vehicle if you experience these effects.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Rabitra I 20mg/150mg sustained-release capsules in individuals with renal impairment. Physician consultation is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should exercise caution when using Rabitra I 20mg/150mg sustained-release capsules. Dosage modification of Rabitra I 20mg/150mg sustained-release capsules may be necessary. Physician consultation is advised.

What if you forget to take Rabitra I 20mg/150mg Capsule SR :

Should you forget a Rabitra I 20mg/150mg SR Capsule, take it immediately if you remember. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Rabitra I 20mg/150mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Medication Stomach and intestinal
Rabitra I 20mg/150mg Caps...
112
MRP 137
18% off